Back
iShares Neuroscience and Healthcare ETF Quote, Financials, Valuation and Earnings
Sponsored
IBRN
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
78
IBRN
iShares Neuroscience and Healthcare ETF
Last Price:
25.95
Seasonality Move:
13.01%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.iShares Neuroscience and Healthcare ETF Price Quote
$25.95
-0.55 (0.23%)
(Updated: November 23, 2024 at 5:39 AM ET)
iShares Neuroscience and Healthcare ETF Key Stats
Buy
78
iShares Neuroscience and Healthcare ETF (IBRN)
is a Buy
Day range:
$26.19 - $26.57
52-week range:
$21.02 - $28.74
Dividend yield:
0.02%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
549
Avg. volume:
373
1-year change:
26.56%
Market cap:
$0
Revenue:
$0
EPS:
$0
How Much Does iShares Neuroscience and Healthcare ETF Make?
Data Unavailable
Is iShares Neuroscience and Healthcare ETF Growing As A Company?
Data Unavailable
iShares Neuroscience and Healthcare ETF Stock Price Performance
-
Did iShares Neuroscience and Healthcare ETF Stock Go Up Last Month?
iShares Neuroscience and Healthcare ETF share price went down by -2.58% last month -
Did IBRN's Share Price Rise Over The Last Year?
IBRN share price rose by 26.56% over the past 1 year
What Is iShares Neuroscience and Healthcare ETF 52-Week High & Low?
-
What Is iShares Neuroscience and Healthcare ETF’s 52-Week High Share Price?
iShares Neuroscience and Healthcare ETF has traded as high as $28.74 over the past 52 weeks -
What Is iShares Neuroscience and Healthcare ETF’s 52-Week Low Share Price?
iShares Neuroscience and Healthcare ETF has traded as low as $21.02 over the past 52 weeks
iShares Neuroscience and Healthcare ETF Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy iShares Neuroscience and Healthcare ETF?
Data Unavailable
Is iShares Neuroscience and Healthcare ETF Cash Flow Positive?
Data Unavailable
iShares Neuroscience and Healthcare ETF Return On Invested Capital
Data Unavailable
iShares Neuroscience and Healthcare ETF Earnings Date & Stock Price
-
What Is iShares Neuroscience and Healthcare ETF's Stock Price Today?
A single share of IBRN can be purchased today for 26.50 -
What Is iShares Neuroscience and Healthcare ETF’s Stock Symbol?
iShares Neuroscience and Healthcare ETF trades on the nysearca under the ticker symbol: IBRN -
When Is iShares Neuroscience and Healthcare ETF’s Next Earnings Date?
The next quarterly earnings date for iShares Neuroscience and Healthcare ETF is scheduled on November 25, 2024 -
When Is IBRN's next ex-dividend date?
iShares Neuroscience and Healthcare ETF's next ex-dividend date is December 20, 2023 -
How To Buy iShares Neuroscience and Healthcare ETF Stock?
You can buy iShares Neuroscience and Healthcare ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
iShares Neuroscience and Healthcare ETF Competitors
-
Who Are iShares Neuroscience and Healthcare ETF's Competitors?
Below is a list of companies who compete with iShares Neuroscience and Healthcare ETF or are related in some way:
iShares Neuroscience and Healthcare ETF Dividend Yield
-
What Is IBRN Dividend Yield?
iShares Neuroscience and Healthcare ETF’s dividend yield currently is 0.02% -
What Is iShares Neuroscience and Healthcare ETF’s Payout Ratio?
iShares Neuroscience and Healthcare ETF’s payout ratio is 0% -
When Did iShares Neuroscience and Healthcare ETF Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is iShares Neuroscience and Healthcare ETF’s Dividend Per Share?
iShares Neuroscience and Healthcare ETF pays a dividend of $0.00 per share
iShares Neuroscience and Healthcare ETF Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable